Neoadjuvant chemotherapy in oesophageal adenocarcinoma - Authors' reply

Lancet Oncol. 2017 Nov;18(11):e641. doi: 10.1016/S1470-2045(17)30776-3. Epub 2017 Oct 31.

Authors

Derek Alderson¹, Matthew Nankivell², Ruth Langley², David Cunningham³

Affiliations

¹ Queen Elizabeth Hospital, Birmingham, UK.
² Medical Research Council Clinical Trials Unit at UCL, London, UK.
³ Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. Electronic address: david.cunningham@rmh.nhs.uk.

PMID: 29208395
DOI: 10.1016/S1470-2045(17)30776-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Adenocarcinoma
Esophageal Neoplasms*
Humans
Neoadjuvant Therapy*

Grants and funding